Get started
Author

Parul Berry

ORCID: 0000-0002-0860-4496
Observed ORCID: 0000-0002-0860-4496
OpenAlex ID: A5035619348
Risk factors for Coronavirus disease-associated mucormycosis
2021 · Umang Arora, Megha Priyadarshi, et al. · Journal of Infection · 73
PDF
SARS-CoV-2 epidemic in India: epidemiological features and in silico analysis of the effect of interventions
2020 · Archisman Mazumder, Mehak Arora, et al. · F1000Research · 38
Association of Sociodemographic Parameters With Depression, Anxiety, Stress, Sleep Quality, Psychological Trauma, Mental Well-Being, and Resilience During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Survey From India
2021 · Tanveer Kaur, Piyush Ranjan, et al. · Cureus · 31
PDF
Assessment of Preventive Practices Followed by General Public During COVID-19 Pandemic - A Cross-Sectional Survey From India
2020 · Avinash Chakrawarty, Piyush Ranjan, et al. · Cureus · 29
PDF
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies
2023 · Parul Berry, Sahil Khanna · BioDrugs · 22
Utilizing large language models for gastroenterology research: a conceptual framework
2025 · Parul Berry, Rohan Raju Dhanakshirur, et al. · Therapeutic Advances in Gastroenterology · 21
Prevalence and Correlates of Vitamin D Deficiency among Adult Population in Urban and Rural Areas of the National Capital Region of Delhi, India
2023 · Pradeep A. Praveen, Archna Singh, et al. · WHO South-East Asia Journal of Public Health · 11
Effectiveness and Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Immunocompromised Patients
2025 · Parul Berry, Raseen Tariq, et al. · Clinical Gastroenterology and Hepatology · 10
Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection
2024 · Parul Berry, Sahil Khanna · Future Microbiology · 5
Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India
2020 · Archisman Mazumder, Vishwesh Bharadiya, et al. · medRxiv · 5
PDF
Diagnostic Approaches for Clostridioides difficile Infection
2025 · Parul Berry, Sahil Khanna · Infectious Disease Clinics of North America · 4
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection
2025 · Parul Berry, Sahil Khanna · Indian Journal of Gastroenterology · 4
Novel Risk Factors for Coronavirus Disease-Associated Mucormycosis (CAM): A Case Control Study During the Outbreak in India
2021 · Umang Arora, Megha Priyadarshi, et al. · SSRN Electronic Journal · 4
Real-world use of bezlotoxumab to prevent recurrent Clostridioides difficile infections: a single-center experience and meta-analysis
2025 · Kanika Sehgal, Parul Berry, et al. · Therapeutic Advances in Gastroenterology · 3
Establishing Apolipoprotein-B and non-high-density-lipoprotein-C goals in Indian population: A Cross-sectional study
2024 · Parul Berry, Ritvik Amarchand, et al. · Indian Heart Journal · 3
Burden of Emergency Department Visits and Their Outcomes Among Patients With Rheumatoid Arthritis: Insights From the Nationwide Emergency Department Sample
2025 · Vishwesh Bharadiya, Parul Berry, et al. · ACR Open Rheumatology · 2
PDF
Body mass index changes after fecal microbiota transplantation for recurrent Clostridioides difficile infection
2025 · Kanika Sehgal, Parul Berry, et al. · Therapeutic Advances in Gastroenterology · 2
Impact of school closure during COVID-19 pandemic on school-going children in a rural population of Haryana: A qualitative study
2024 · Suprakash Mandal, Mohamed S. Hasan, et al. · Journal of Family Medicine and Primary Care · 2
Cost-Effectiveness of Microbiota Restoration Therapies for Recurrent Clostridioides difficile Infection
2026 · Parul Berry, Vishwesh Bharadiya, et al. · The American Journal of Gastroenterology · 1
Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection
2026 · Parul Berry, Jessica R. Allegretti, et al. · Gastroenterology Clinics of North America · 1
Mo2004: COST-EFFECTIVENESS ANALYSIS OF FECAL MICROBIOTA SPORES, LIVEBRPK AND FECAL MICROBIOTA, LIVE-JSLM IN MANAGING FIRST AND SECOND RECURRENCE OF CLOSTRIDIOIDES DIFFICILE INFECTION
2025 · Parul Berry, Elida Voth, et al. · Gastroenterology · 1
S2099 Efficacy of Microbiota-Based Therapies in the Management of Obesity: A Meta-Analysis
2024 · Parul Berry, Raseen Tariq, et al. · The American Journal of Gastroenterology · 1
Barriers to Diagnosis and Treatment of Clostridioides difficile Infection: A Narrative Review
2026 · Parul Berry, Vishwesh Bharadiya, et al. · Antibiotics
From manual parametric to artificial intelligence-based automation: A systematic review of recent advances in endoscopic surgical skills evaluation
2026 · Rohan Raju Dhanakshirur, Ramandeep Singh, et al. · Journal of Minimal Access Surgery
Unravelling the Inflammatory and Metabolic Insights in Subacute Sclerosing Panencephalitis: A Prospective Multimodal Evaluation
2025 · Prashant Jauhari, Sakshi Ojha, et al. · Pediatric Neurology
Works count: 35
Citation count: 273
H-index: 8
I10-index: 8
Year
Topic
Type